📰 Human Use News
Page 90 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
February 14, 2023
14.02.2023 - Pre-launch commercial activities underway as Company advances toward U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) goal date of August 29, 2023 for ONS-5010 / LYTENAVA (bevacizumab-vikg), an investigational ...
February 14, 2023
This Week in Washington: President Biden delivers State of the Union Address, House votes to end CDC COVID-19 Foreign Air Traveler Vaccine Mandate...
February 9, 2023
The European Commission has expanded the indication of the SGLT2 inhibitor to include HF with mildly reduced and preserved ejection fraction, based on the DELIVER phase 3 trial.
February 9, 2023
2022 total sales up by 8.5% at CER1 (14.4% as reported) with growth platforms'2 sales increasing by 20.9%1 and Somatuline® (lanreotide) sales declining by 5.6%12022 core operating margin of 36.9%, broadly
February 9, 2023
2022 total sales up by 8.5% at CER1 (14.4% as reported) with growth platforms’2 sales increasing by 20.9%1 and Somatuline® (lanreotide) sales declining by 5.6%1
February 8, 2023
Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure - News - PharmaTimes
February 8, 2023
L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...
February 8, 2023
On January 16, 2023, STADA Arzneimittel AG (STADA) and Xbrane Biopharyma AB (Xbrane) announced that the UK's Medicines and Healthcare product Regulatory Agency (MHRA)...
February 8, 2023
CHMP determined CyclASol is eligible for a centralised procedure Novaliq has submitted a Letter of intent to file a Marketing Authorisation Application (MAA) in July 2023 Novaliq, a biopharmaceutical
February 7, 2023
This Week in Washington: President Biden announces ending date of COVID-19 PHE, House begins investigations into COVID-19 origins; State of the Union scheduled for Feb. 7...